Brighten Optix Corporation (6747) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Brighten Optix Corporation (6747:TWSE), powered by AI.

Current Price
$199.00
P/E Ratio
36.1
Market Cap
5.4B
Sector
Healthcare
What is the Brighten Optix Corporation stock price forecast?

Brighten Optix Corporation is currently trading at $199.00. View real-time AI analysis on Alpha Lenz.

What is Brighten Optix Corporation insider trading activity?

View the latest insider trading data for Brighten Optix Corporation on Alpha Lenz.

What is Brighten Optix Corporation's P/E ratio?

Brighten Optix Corporation's P/E ratio is 36.1.

Brighten Optix Corporation

TWSE · 6747
NT$199.00+0.00(+0.00%)
Ask about Brighten Optix Corporation's future dividend policy...
Alpha Chat Insight

Brighten Optix Corporation trades at a P/E of 36.1 (premium valuation) with solid ROE of 11.2%.

Ask for details

Company Overview

Brighten Optix Corporation is a medical device company specializing in the research, development, manufacture, and sale of contact lenses, with a significant presence in both Taiwan and international markets. Its comprehensive product portfolio includes innovative orthokeratology lenses, which non-invasively reshape the cornea for vision correction, rigid gas-permeable lenses addressing needs such as multifocal vision and irregular corneas, and a variety of soft contact lenses under several proprietary brands. The company also offers spectacle lenses, particularly for pediatric myopia management, as well as lens care solutions and rewetting drops. With roots dating back to 1965, Brighten Optix has played a pioneering role in Taiwan’s eye care industry, continually investing in high oxygen permeability and advanced lens designs. Positioned within the healthcare sector and classified under medical specialties, the firm serves a diverse clientele across consumer, clinical, and wholesale channels, helping to shape visual performance solutions in Asia and beyond.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2024

Profile

NT$5.41BMarket Cap
NT$766.93MRevenue
0.00Shares Out
0Employees

Margins

65.66%Gross
28.70%EBITDA
18.22%Operating
23.09%Pre-Tax
19.22%Net

Valuation

36.14P/E
3.84P/B
7.06EV/Sales
21.76EV/EBITDA
32.45P/FCF

Growth (CAGR)

5.96%Rev 3Yr
9.45%Rev 5Yr
-14.99%Op Inc 3Yr
1.71%Op Inc 5Yr
-15.04%Net Inc 3Yr
5.11%Net Inc 5Yr

Returns

9.58%ROA
11.16%ROE
11.57%ROIC

Financial Health

NT$655.53MCash & Cash Equivalents
NT$-475.06MNet Debt
12.76%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Brighten Optix Corporation (ticker: 6747) is a company listed on TWSE in the Healthcare sector (Medical Devices). Market cap is $5.4B.

The current price is 199 with a P/E ratio of 36.14x and P/B of 3.84x.

ROE is 11.16% and operating margin is 18.22%. Annual revenue is $767M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Brighten Optix Corporation (6747) Stock Forecast 2026 $199.00 — Price, Financials & Analyst Targets | Alpha Lenz